The GTPBP1 knockout HT29 polyclonal cells represent a CRISPR/Cas9-engineered population with targeted disruption of the GTPBP1 gene. This heterogeneous knockout pool, generated without clonal isolation, provides a robust loss-of-function model to investigate GTPBP1-dependent processes, including ribosome rescue, translation elongation, and stress granule dynamics. Because the polyclonal format avoids artifacts associated with single-cell cloning, it better preserves the biological diversity of the HT29 background and allows more physiologically relevant assessments of GTPBP1 function.
HT29 is a human colorectal adenocarcinoma cell line of epithelial origin, derived from a female Caucasian patient. This widely used model harbors inactivating mutations in APC and TP53 and retains differentiated intestinal epithelial characteristics, making it relevant for translational control and cancer biology studies. The HT29 background provides a malignant epithelial context to evaluate GTPBP1-mediated ribosome rescue in colorectal tumorigenesis.
GTPBP1 encodes a ribosome rescue factor that dissociates stalled ribosomes by partnering with the 60S subunit, PELOTA, HBS1L, and eEF1A. This activity is controlled by mTOR signaling and eIF2?? kinases (GCN2, PERK, PKR, HRI) downstream of cellular stresses such as nutrient deprivation and oxidative load. GTPBP1-mediated ribosome recycling regulates translation elongation and represses aberrant stress granule formation, thereby maintaining proteostasis. Its loss disrupts these processes, causing ribosome stalling, altered translation dynamics, and increased stress granule assembly under stress.
Within the HT29 colorectal adenocarcinoma model, GTPBP1 knockout provides a platform to investigate how ribosome rescue defects influence cancer cell proliferation, survival, and stress responses. Colorectal tumors often upregulate protein synthesis and rely on stress-adaptive pathways, making this model valuable for studying the interplay between GTPBP1-dependent proteostasis and oncogenic signaling. It can be used to explore mechanisms of chemoresistance and metabolic adaptation linked to translation control.
This knockout model supports polysome profiling, stress granule immunofluorescence, translatome analysis, co-immunoprecipitation of ribosomal complexes, and cell viability assays under stress. Applications include mechanistic studies of ribosome rescue, screening of ribosome-targeting compounds, and translational control research in colorectal cancer. For further details, contact Ascent Research.
